Furthermore, DORAs, as the name suggests, antagonize both orexin receptors, while OXA which preferentially binds to the OX1R, has demonstrated antinociceptive actions in preclinical models of migraine, whereas OXB demonstrated largely pronociceptive effects. This evidence concerns the gene HCRTR1 and migraine disorder.